Učitavanje...
The Use of Gene Therapy for Ablation of Atrial Fibrillation
Atrial fibrillation is the most common clinically significant cardiac arrhythmia, increasing the risk of stroke, heart failure and morbidity and mortality. Current therapies, including rate control and rhythm control by antiarrhythmic drugs or ablation therapy, are moderately effective but far from...
Spremljeno u:
| Izdano u: | Arrhythm Electrophysiol Rev |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Radcliffe Cardiology
2014
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4711550/ https://ncbi.nlm.nih.gov/pubmed/26835081 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15420/aer.2014.3.3.139 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|